Gujarat Themis Biosyn Amends Articles of Association Post EGM Approval
Gujarat Themis Biosyn Limited shareholders approved an amendment to the Articles of Association at an EGM on August 22, 2026. The change modifies Article 13(1) Clause (c) concerning share issuance terms.
The amendment to the Articles of Association is a procedural change and does not immediately impact the company's financial performance or operational outlook. Its impact is therefore considered low.
The announcement is a procedural update regarding amendments to the company's Articles of Association, which does not inherently carry a positive or negative financial implication at this stage. It is a routine corporate action.
Gujarat Themis Biosyn Limited announced that its shareholders have approved an amendment to the Articles of Association (AOA) of the company. The approval was granted via a Special Resolution passed at the Extraordinary General Meeting (EGM) held on August 22, 2026.
The amendment specifically pertains to Article 13(1) Clause (c). The words "if the price of such shares is determined by a registered valuer or a valuer approved for this purpose, who shall submit a valuation report in that behalf, subject to such conditions as may be prescribed" have been deleted from the clause.
Following this amendment, Clause (c) of Article 13(1) will now read: "Any persons, whether or not those persons include the persons referred to in clause (a) or clause (b) above, either for cash or for a consideration other than cash." This change modifies the existing provisions related to share issuance and valuation.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.